RB1 and posterior cortical atrophy: As early as 1998, it was observed that a higher frequency of RB1 mRNA downregulation occurred in patients with PCa relapsed after combined androgen blockade therapy, suggesting that RB1 inactivation contributes to hormone therapy resistance [154].